Fresenius Medical Care's Versi®HD with GuideMe Software Receives FDA Clearance

Fresenius Medical Care has received FDA clearance for Versi®HD with GuideMe Software, a self-guided interface for their VersiHD chronic home hemodialysis (HHD) system. The software aims to enhance the ease of use and confidence for both patients and nurses, improving patient training time and making the transition to home dialysis easier. The company is committed to providing cutting-edge solutions to improve the health and well-being of dialysis patients. VersiHD with GuideMe Software will be available in selected markets in 2023.